Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Hold ACE inhibitors and ARBs before noncardiac surgery? Emerging evidence suggests a patient-specific approach
Maureen Keshock1, Elise Zhang2, Christopher Whinney3
1Department of Regional Practice Anesthesiology, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH keshocm@ccf.org.
Abstract:
Although withholding these drugs before noncardiac surgery reduces the risk of intraoperative hypotension, recent trials suggest that it leads to harm in sicker patients. An individualized approach is safest, particularly in patients with heart failure. This review examines the emerging evidence regarding the impact of pausing vs continuing these drugs on intraoperative hypotension, myocardial injury, acute kidney injury, and postoperative outcomes.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Aortic Regurgitation III: Medical Management
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Pre-Procedural Guidelines for Assessing Blood Pressure

